ClinicalTrials.Veeva

Menu

Proof-of-concept Study of Blood Markers of Tumor Dissemination in Patients with Versus Without Intestinal Polyps (EARDIS)

C

Centre Hospitalier Universitaire de Nīmes

Status

Enrolling

Conditions

Neoplasm Metastasis
Colorectal Cancer
Disseminated Cancer

Treatments

Other: Blood test

Study type

Observational

Funder types

Other

Identifiers

NCT05648240
NIMAO/2022-1/JFB01

Details and patient eligibility

About

The study authors hypothesize that in patients with intestinal polyps, tumor cells could disseminate and circulating factors could be secreted by the polyp. These two parameters could become biomarkers to refine the follow-up of patients and to establish targeted therapeutic strategies.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient to be examined by colonoscopy
  • The patient must be a member or beneficiary of a health insurance plan

Exclusion criteria

  • The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study
  • The subject signals their opposition to participate in the study
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • Patient pregnant or breastfeeding
  • History of proven cancerous disease
  • Patient followed for a chronic inflammatory bowel disease

Trial design

120 participants in 2 patient groups

Patients with polyps
Treatment:
Other: Blood test
Patients without polyps
Treatment:
Other: Blood test

Trial contacts and locations

1

Loading...

Central trial contact

Jean-François BOURGAUX

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems